United StatesHealthcare and life sciences2025 – ongoingMerck & Co. (MSD)
Generative AI drafting of clinical study reports
Merck reported cutting human-reviewed clinical report draft effort from 180 to 80 hours
Problem
Medical writers had to reconcile large volumes of clinical data and prepare reports in regulatory language.
Approach
Merck combined table preprocessing with LLM drafting under medical-writer oversight. Teams produced and submitted the first live clinical study reports using the platform in early 2025.
Results
Takeaway
The reported effort reduction included human review. It did not establish a measured reduction in medicine approval time.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- IT and R&DInternal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
Merck reported submitted clinical reports using its new platform. It claimed lower human-reviewed drafting effort and a 50% reduction in errors across multiple studies.
Full details are in the original sources.